Risk & Weakness
Insolvency Radar: Cash Running Low
207 Findings · last calculated November 2, 2026 Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · showing the 100 strongest hits
Methodology & criteria
The mirror image of the Graham Net-Net shopping list: instead of companies with a bulging current-asset cushion, this scanner finds companies that are running out of cash. Criteria: the operating business is burning cash (operating cash flow over the trailing four quarters is negative in total), and cash plus short-term investments would last less than four quarters at the current burn rate. Unlike score-based early warnings (Altman Z, the Going Concern proxy), this scanner calculates specifically how long the cash will last. Banks and financial services companies are excluded (their cash flow fluctuates for structural reasons and isn't a valid burn rate), as are micro-caps under $20 million in market cap and obvious data outliers. Important: a hit is not a bankruptcy verdict — many of these companies save themselves through a capital raise or credit line, diluting existing shareholders in the process. For portfolio holders, an early-warning system; for bargain hunters, the opposite of a shopping list. Source: fundamental data.
No global trading filters — this strategy checks the entire stock universe purely against its own criteria (mega caps over $50B included).
🔔 Watch scanner
Hit List
Tip: clicking a column header sorts the table by that column; a second click flips the direction.
| Symbol | Earnings | Avg/Y 3Y | Volatility | Stage | Funda Rating | Piotroski | MktCap | Industry | AI Rating | Deep Dive | Deep-Dive Report | Sector | Price | YTD | 6 Mo. | 1 Year | Off High | Price Target | RS | EPS Rating | ADR 10D | ADR 30D | Beta | P/E | P/E (f) | P/S | P/B | P/FCF | PEG | EV/EBITDA | EBIT Margin | Gross Margin | Net Margin | ROE | ROA | Debt/Eq | Equity Ratio | Sales +/Y | Growth Score | Div. Yield | Payout Ratio | Altman Z | Inst. % | Short % | Analysts |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OTLK OUTLOOK THERAPEUTICS INC | 08/13 | -32 % | ⚠ Wildest 10% 164 % | Stage 3 | D 33 | 4 of 9 | 0.1 $ | Biotechnology | Uses AI | — | Healthcare | 0.4681 $ | +7.6 % | -7.7 % | -61.5 % | −52.5 % | +848.5 % | 97 | 42 | 16.8 % | 20.7 % | 0.67 | — | 2.8 | — | — | — | — | -4.1 | — | -360.8 % | 0.0 % | -3.7 % | -143.2 % | — | — | +730.9 % | 3 | 0.0 % | 0.0 % | -116.1 | 6.9 % | 13.9 % | 4.5 (4) | |
| PIII P3 Health Partners Inc | 08/13 | -33 % | ⚠ Wildest 10% 159 % | Stage 2 | C 51 | 6 of 9 | 0.0 $ | Medical Care Facilities | Uses AI | — | — | Healthcare | 4.00 $ | +243.6 % | +18.1 % | -51.5 % | −36.8 % | +373.7 % | 97 | 42 | 10.2 % | 16.8 % | 1.69 | — | 0.0 | 0.0 | 0.2 | — | — | -1.9 | — | 4.7 % | -6.6 % | -6,952.6 % | -13.4 % | -0.43 | — | -2.8 % | 2 | 0.0 % | 0.0 % | -5.7 | 7.3 % | 0.4 % | 4.0 (2) |
| CELC Celcuity LLC | 08/13 | +65 % | 65 % | Stage 1 | D 40 | 2 of 9 | 3.4 $ | Biotechnology | Neutral | — | — | Healthcare | 69.10 $ | -9.6 % | -0.1 % | -6.4 % | −36.5 % | +122.6 % | 96 | 42 | 5.5 % | 7.2 % | 0.11 | — | 0.0 | — | — | — | — | -7.8 | 0.0 % | — | 0.0 % | -275.2 % | -25.8 % | — | 13.1 % | — | 4 | 0.0 % | 0.0 % | 2.6 | 101.2 % | 31.4 % | 4.8 (13) |
| SVCO Silvaco Group, Inc. | 08/05 | — | ⚠ Wildest 10% 89 % | Stage 2 | C 53 | 4 of 9 | 0.2 $ | Software - Application | Sells AI | — | — | Technology | 6.10 $ | +218.0 % | +185.7 % | +6.0 % | −15.5 % | +123.0 % | 96 | 42 | 9.8 % | 9.6 % | 0.42 | — | 20.7 | 2.8 | 2.4 | — | — | 194.4 | — | 83.2 % | -30.4 % | -34.7 % | -9.6 % | 0.03 | — | +5.7 % | 4 | 0.0 % | 0.0 % | 2.2 | 24.3 % | 14.5 % | 4.8 (6) |
| SKYT Skywater Technology Inc | 08/05 | +114 % | ⚠ Wildest 10% 90 % | Stage 2 | B 66 | 4 of 9 | 1.6 $ | Semiconductors | Neutral | — | — | Technology | 32.50 $ | +101.2 % | +99.1 % | +239.9 % | −12.9 % | +7.7 % | 95 | 99 | 5.1 % | 4.8 % | 3.27 | 14.2 | 185.2 | 2.6 | 8.9 | — | — | 11.8 | -3.3 % | 20.2 % | 18.4 % | 95.9 % | 0.3 % | 1.32 | 24.6 % | +29.2 % | 4 | 0.0 % | 0.0 % | 2.8 | 61.4 % | 7.3 % | 4.2 (5) |
| URGN UroGen Pharma Ltd | 08/06 | +18 % | 62 % | Stage 2 | B 63 | 3 of 9 | 1.6 $ | Biotechnology | Uses AI | — | — | Healthcare | 32.70 $ | +50.1 % | +51.8 % | +69.3 % | −4.7 % | +77.5 % | 94 | 42 | 5.1 % | 5.4 % | 1.58 | — | 29.9 | 8.3 | — | — | — | -2.6 | -39.8 % | 90.9 % | -51.7 % | -1,481.3 % | -18.1 % | — | -49.0 % | +21.5 % | 4 | 0.0 % | 0.0 % | -8.0 | 100.6 % | 11.7 % | 4.6 (8) |
| GCTS GCT Semiconductor Holding Inc | 08/11 | -32 % | ⚠ Wildest 10% 96 % | Stage 2 | D 44 | 6 of 9 | 0.1 $ | Semiconductors | Neutral | — | — | Technology | 1.10 $ | +139.2 % | +106.5 % | -13.2 % | −37.2 % | +146.2 % | 94 | 42 | 11.3 % | 15.8 % | 1.78 | — | 0.0 | 24.4 | 0.0 | — | — | -21.3 | — | -38.3 % | 0.0 % | 0.0 % | -64.4 % | -0.79 | — | -68.6 % | 3 | 0.0 % | 0.0 % | -114.5 | 4.9 % | 12.1 % | 5.0 (1) |
| QMCO Quantum Corporation | — | -32 % | ⚠ Wildest 10% 109 % | Stage 2 | D 37 | 4 of 9 | 0.6 $ | Computer Hardware | Uses AI | — | Technology | 18.30 $ | +114.1 % | +60.8 % | +115.7 % | −30.0 % | +49.4 % | 94 | 42 | 14.0 % | 14.5 % | 3.09 | — | 1.9 | 1.9 | 0.2 | — | 0.77 | 236.9 | — | 37.8 % | -80.8 % | 0.0 % | -0.4 % | -0.04 | — | -12.1 % | 1 | 0.0 % | 0.0 % | -26.0 | 12.8 % | 58.6 % | 5.0 (3) | |
| PGEN Precigen Inc | 08/11 | +125 % | 77 % | Stage 2 | B 64 | 4 of 9 | 2.5 $ | Biotechnology | Neutral | — | — | Healthcare | 6.90 $ | +28.2 % | +41.3 % | +65.6 % | −2.8 % | +123.8 % | 93 | 42 | 6.5 % | 6.9 % | 0.92 | — | 13.7 | 28.7 | 136.7 | — | — | -3.3 | -25.8 % | 53.0 % | -184.0 % | -1,145.4 % | -18.1 % | 4.86 | 14.6 % | +146.7 % | 2 | 0.0 % | 0.0 % | -57.6 | 71.1 % | 24.4 % | 4.3 (4) |
| ARMP Armata Pharmaceuticals Inc | 08/11 | +51 % | ⚠ Wildest 10% 111 % | Stage 1 | D 35 | 4 of 9 | 0.1 $ | Biotechnology | Neutral | — | — | Healthcare | 3.30 $ | +11.6 % | +0.8 % | -40.5 % | −60.2 % | +400.0 % | 91 | 42 | 11.0 % | 10.5 % | 1.41 | — | 0.0 | — | — | — | — | 14.4 | — | -217.4 % | 0.0 % | -3,439.4 % | -25.8 % | — | — | -5.2 % | 3 | 0.0 % | 0.0 % | -52.2 | 10.5 % | 8.6 % | 4.0 (1) |
| CLPT Clearpoint Neuro Inc | 08/11 | +61 % | ⚠ Wildest 10% 89 % | Stage 3 | D 40 | 4 of 9 | 0.3 $ | Medical Devices | Neutral | — | — | Healthcare | 10.70 $ | +35.5 % | +34.1 % | -55.7 % | −40.3 % | +161.1 % | 90 | 42 | 11.6 % | 9.0 % | 1.29 | — | 12.1 | 7.1 | 18.0 | — | 0.61 | -7.1 | — | 62.6 % | -81.8 % | -149.7 % | -24.4 % | 3.38 | — | +17.8 % | 3 | 0.0 % | 0.0 % | -3.1 | 50.6 % | 16.2 % | 5.0 (2) |
| SPIR Spire Global Inc | 08/12 | +124 % | ⚠ Wildest 10% 100 % | Stage 2 | C 48 | 4 of 9 | 0.4 $ | Specialty Business Services | Sells AI | — | — | Industrials | 8.90 $ | +132.5 % | +114.7 % | -9.2 % | −38.3 % | +129.4 % | 90 | 42 | 9.1 % | 11.1 % | 2.81 | 5.4 | 0.0 | 5.7 | 3.8 | — | — | 7.8 | — | 37.9 % | -145.2 % | 101.2 % | -22.0 % | 0.13 | — | -35.2 % | 4 | 0.0 % | 0.0 % | -8.1 | 39.9 % | 10.3 % | 5.0 (4) |
| BTDR Bitdeer Technologies Group | 08/17 | +17 % | ⚠ Wildest 10% 103 % | Stage 3 | B 63 | 3 of 9 | 1.7 $ | Software - Application | Sells AI | — | Technology | 6.70 $ | +53.7 % | +38.0 % | -67.2 % | −41.0 % | +180.3 % | 89 | 42 | 10.6 % | 10.4 % | 2.56 | — | 6.1 | 2.2 | 2.1 | — | — | 14.4 | -43.4 % | 0.7 % | -28.1 % | -26.1 % | 4.3 % | 2.78 | 23.5 % | +77.3 % | 4 | 0.0 % | 0.0 % | 4.7 | 70.9 % | 33.4 % | 4.6 (14) | |
| AVT Avnet Inc | 08/05 | +35 % | 38 % | Stage 2 | B 64 | 5 of 9 | 7.2 $ | Electronics & Computer Distribution | Neutral | — | Technology | 88.20 $ | +88.1 % | +79.7 % | +94.0 % | −4.7 % | +13.5 % | 89 | 60 | 3.2 % | 3.6 % | 1.08 | 31.3 | 7.1 | 0.3 | 1.4 | — | 2.65 | 12.5 | 3.1 % | 10.4 % | 1.2 % | 4.4 % | 3.9 % | 0.77 | 36.7 % | -6.6 % | 3 | 1.7 % | 25.1 % | 7.8 | 110.1 % | 11.0 % | 3.5 (4) | |
| GLSI Greenwich Lifesciences Inc | 08/13 | +46 % | ⚠ Wildest 10% 105 % | Stage 2 | D 28 | 5 of 9 | 0.3 $ | Biotechnology | Neutral | — | — | Healthcare | 17.40 $ | +9.6 % | +35.1 % | +107.7 % | −46.3 % | +227.6 % | 89 | 42 | 11.0 % | 9.4 % | 1.46 | — | 0.0 | — | 49.6 | — | — | -21.2 | — | — | 0.0 % | -676.7 % | -236.0 % | — | — | — | — | 0.0 % | 0.0 % | -19.1 | 12.4 % | 20.7 % | 5.0 (2) |
| NRXP NRX Pharmaceuticals Inc | 08/17 | -8 % | ⚠ Wildest 10% 83 % | Stage 2 | B 58 | 6 of 9 | 0.1 $ | Biotechnology | Neutral | — | — | Healthcare | 2.30 $ | +38.7 % | +63.9 % | -12.8 % | −29.6 % | +1,325.9 % | 89 | 42 | 8.5 % | 10.2 % | 2.07 | — | 34.2 | 31.2 | — | — | — | -0.2 | — | 46.6 % | 0.0 % | -682.6 % | -64.0 % | — | — | — | — | 0.0 % | 0.0 % | -97.1 | 17.5 % | 23.6 % | 5.0 (4) |
| NVRI Enviri Corporation | 08/04 | +48 % | 46 % | Stage 2 | D 32 | 3 of 9 | 0.5 $ | Waste Management | – | — | — | Industrials | 18.50 $ | +22.5 % | +20.1 % | +49.1 % | −7.6 % | +50.1 % | 88 | 8 | 5.0 % | 6.5 % | 1.60 | — | 13.2 | 0.3 | 6.8 | — | 2.11 | 68.7 | — | 13.8 % | -24.4 % | -44.6 % | -3.8 % | -2.66 | — | -9.7 % | 3 | 0.0 % | 0.0 % | 5.6 | 5.9 % | 15.2 % | 4.0 (3) |
| SHLS Shoals Technologies Group Inc | 08/04 | -19 % | ⚠ Wildest 10% 86 % | Stage 2 | B 62 | 2 of 9 | 1.3 $ | Solar | Neutral | — | Technology | 7.20 $ | +20.9 % | +1.1 % | -28.9 % | −25.2 % | +45.5 % | 87 | 66 | 8.6 % | 9.1 % | 1.85 | — | 12.2 | 2.2 | — | — | 0.51 | 20.1 | 8.1 % | 32.1 % | 5.4 % | 5.8 % | 5.8 % | — | 58.4 % | +19.1 % | 3 | 0.0 % | 0.0 % | 6.6 | 121.3 % | 13.2 % | 4.0 (19) | |
| ECOR Electrocore LLC | 08/05 | +35 % | ⚠ Wildest 10% 87 % | Stage 2 | C 53 | 4 of 9 | 0.1 $ | Medical Devices | – | — | — | Healthcare | 7.50 $ | +86.2 % | +66.4 % | +60.9 % | −31.5 % | +145.8 % | 87 | 42 | 11.0 % | 11.5 % | 1.05 | — | 384.6 | 1.8 | 39.5 | — | — | 0.2 | — | 87.1 % | -40.0 % | -478.7 % | -55.0 % | -1.67 | — | +27.2 % | 6 | 0.0 % | 0.0 % | -44.7 | 9.2 % | 3.6 % | 4.8 (5) |
| HURA TuHURA Biosciences Inc | 08/13 | -33 % | ⚠ Wildest 10% 126 % | Stage 3 | D 31 | 3 of 9 | 0.1 $ | Biotechnology | Neutral | — | Healthcare | 1.90 $ | +248.7 % | +177.9 % | -15.9 % | −33.6 % | +282.9 % | 86 | 42 | 10.2 % | 9.0 % | -0.84 | — | 0.0 | — | — | — | — | 0.0 | — | — | 0.0 % | -187.2 % | -58.4 % | — | — | — | 2 | 0.0 % | 0.0 % | -16.0 | 15.0 % | 12.4 % | 4.5 (4) | |
| BZFD BuzzFeed Inc | 08/06 | -20 % | ⚠ Wildest 10% 107 % | Stage 3 | D 26 | 4 of 9 | 0.1 $ | Internet Content & Information | Threatened | — | — | Communication Services | 0.9055 $ | +64.5 % | -12.4 % | -39.8 % | −50.0 % | +5.5 % | 86 | 13 | 10.5 % | 12.3 % | 3.89 | — | 172.4 | 0.4 | — | — | — | -7.7 | — | 39.8 % | -35.8 % | -90.2 % | -7.8 % | — | — | -2.4 % | 2 | 0.0 % | 0.0 % | -12.8 | 10.0 % | 3.3 % | 5.0 (1) |
| ATRA Atara Biotherapeutics Inc | 08/10 | -29 % | ⚠ Wildest 10% 142 % | Stage 3 | D 31 | 4 of 9 | 0.1 $ | Biotechnology | – | — | — | Healthcare | 8.00 $ | -38.3 % | -67.1 % | -39.3 % | −46.6 % | +66.7 % | 85 | 42 | 8.3 % | 8.3 % | 0.22 | — | 16.1 | 11.8 | 12.6 | — | — | 2.2 | — | 75.3 % | -269.4 % | -2,014.9 % | -24.1 % | -0.27 | — | -6.3 % | 7 | 0.0 % | 0.0 % | -327.5 | 52.5 % | 4.4 % | 4.3 (3) |
| CVU CPI Aerostructures Inc | 08/18 | +10 % | 59 % | Stage 2 | B 56 | 1 of 9 | 0.1 $ | Aerospace & Defense | Neutral | — | Industrials | 4.80 $ | +42.9 % | +48.2 % | +110.2 % | 0 % | -20.0 % | 85 | 18 | 5.0 % | 6.7 % | 1.00 | 39.3 | 6.8 | 0.8 | 2.1 | — | 0.52 | 14.7 | 10.5 % | 22.5 % | 5.1 % | 6.6 % | 5.0 % | 0.76 | 34.3 % | -14.6 % | 2 | 0.0 % | 0.0 % | 1.2 | 25.0 % | 0.5 % | — | |
| FTAI FTAI Aviation Ltd. | 08/04 | +283 % | 65 % | Stage 2 | B 68 | 5 of 9 | 19.1 $ | Aerospace & Defense | – | — | — | Industrials | 187.30 $ | +33.6 % | +52.7 % | +1.1 % | −17.0 % | +117.7 % | 83 | 77 | 6.6 % | 6.4 % | 1.57 | 36.4 | 11.2 | 6.1 | 43.5 | — | 3.22 | 17.4 | 22.5 % | 32.2 % | 15.9 % | 233.3 % | 11.4 % | 10.23 | 9.5 % | +43.2 % | 6 | 1.3 % | 34.1 % | 8.0 | 97.2 % | 8.9 % | 4.6 (11) |
| SHIM Shimmick Corporation | 08/13 | — | ⚠ Wildest 10% 86 % | Stage 1 | C 45 | 4 of 9 | 0.1 $ | Engineering & Construction | Neutral | — | — | Industrials | 2.50 $ | +25.3 % | +50.2 % | +9.4 % | −39.7 % | +191.7 % | 83 | 42 | 7.6 % | 8.4 % | 0.86 | — | 5.8 | 0.2 | 45.7 | — | — | 39.7 | — | 10.1 % | -3.8 % | -696.6 % | -3.4 % | -1.33 | — | +2.6 % | 3 | 0.0 % | 0.0 % | 0.3 | 8.7 % | 2.6 % | 5.0 (2) |
| PLUG Plug Power Inc | 08/10 | -24 % | 78 % | Stage 2 | C 49 | 3 of 9 | 2.0 $ | Electrical Equipment & Parts | Uses AI | — | Industrials | 1.40 $ | +37.6 % | +23.3 % | -48.6 % | −43.9 % | +141.9 % | 82 | 42 | 6.8 % | 8.2 % | 2.29 | — | 13.1 | 2.6 | 2.5 | — | 0.84 | -2.2 | -63.6 % | -24.8 % | -220.6 % | -128.8 % | -12.2 % | 1.35 | 31.7 % | +12.9 % | 2 | 0.0 % | 0.0 % | -10.6 | 68.9 % | 23.0 % | 3.2 (19) | |
| AEVA Aeva Technologies, Inc. | 07/30 | +100 % | ⚠ Wildest 10% 113 % | Stage 2 | C 51 | 5 of 9 | 0.7 $ | Software - Infrastructure | Neutral | — | Technology | 9.30 $ | +77.3 % | +90.3 % | -42.6 % | −48.1 % | +171.0 % | 81 | 42 | 12.5 % | 12.1 % | 2.41 | — | 0.0 | 31.3 | 34.1 | — | — | -0.1 | — | 27.2 % | -150.1 % | -516.1 % | -51.7 % | -8.22 | — | +99.4 % | 5 | 0.0 % | 0.0 % | -16.8 | 66.1 % | 20.4 % | 4.2 (5) | |
| ACHV Achieve Life Sciences Inc | 08/06 | -5 % | 81 % | Stage 2 | D 27 | 3 of 9 | 0.7 $ | Biotechnology | – | — | — | Healthcare | 6.80 $ | +0.8 % | +39.7 % | +45.3 % | −7.5 % | +108.1 % | 79 | 42 | 8.7 % | 8.2 % | 2.31 | — | 35.3 | — | — | — | 17.68 | -2.4 | — | — | 0.0 % | -496.2 % | -29.2 % | — | — | -100.0 % | — | 0.0 % | 0.0 % | -29.4 | 61.0 % | 17.4 % | 4.8 (12) |
| PYXS Pyxis Oncology Inc | 08/13 | -7 % | ⚠ Wildest 10% 134 % | Stage 3 | D 41 | 1 of 9 | 0.1 $ | Biotechnology | – | — | — | Healthcare | 1.80 $ | +82.6 % | +157.7 % | -42.9 % | −59.8 % | +381.5 % | 79 | 42 | 12.6 % | 11.3 % | 1.38 | — | 0.0 | — | 3.6 | — | — | 1.1 | — | 78.4 % | 0.0 % | -121.7 % | -62.9 % | 0.58 | — | -14.2 % | 4 | 0.0 % | 0.0 % | -24.8 | 33.9 % | 7.3 % | 4.7 (10) |
| RDZN Roadzen Inc. | — | -31 % | ⚠ Wildest 10% 84 % | Stage 1 | D 43 | 4 of 9 | 0.1 $ | Software - Application | Sells AI | — | — | Technology | 1.10 $ | -36.1 % | -24.9 % | -32.9 % | −43.4 % | +354.5 % | 79 | 42 | 9.6 % | 8.4 % | 1.25 | — | 0.0 | 1.6 | — | — | — | -4.4 | — | 60.7 % | -46.9 % | 0.0 % | -18.9 % | — | — | -5.2 % | 5 | 0.0 % | 0.0 % | -20.2 | 3.0 % | 3.3 % | 4.5 (2) |
| BHVN Biohaven Ltd. | 08/10 | -12 % | ⚠ Wildest 10% 97 % | Stage 3 | C 46 | 2 of 9 | 2.4 $ | Biotechnology | – | — | — | Healthcare | 15.40 $ | +30.9 % | +38.3 % | -9.0 % | −17.4 % | +48.0 % | 78 | 42 | 9.3 % | 8.9 % | 3.20 | — | 0.0 | — | 19.5 | — | — | -2.2 | 0.0 % | — | 0.0 % | -333.0 % | -72.0 % | 2.21 | 27.8 % | -100.0 % | — | 0.0 % | 0.0 % | -16.5 | 97.6 % | 15.2 % | 4.2 (17) |
| UAMY United States Antimony Corporation | 08/11 | +720 % | ⚠ Wildest 10% 118 % | Stage 4 | D 39 | 1 of 9 | 0.4 $ | Other Industrial Metals & Mining | Neutral | — | Basic Materials | 3.00 $ | +39.6 % | +9.6 % | -62.4 % | −65.2 % | +252.2 % | 78 | 50 | 8.1 % | 8.7 % | 0.38 | — | 476.2 | 12.2 | 3.9 | — | — | 9.3 | — | 17.4 % | -44.6 % | -19.7 % | -12.5 % | 0.00 | — | +162.8 % | 6 | 0.0 % | 0.0 % | 11.2 | 57.4 % | 26.1 % | 5.0 (4) | |
| WNC Wabash National Corporation | 07/24 | -16 % | 57 % | Stage 2 | D 33 | 2 of 9 | 0.5 $ | Farm & Heavy Construction Machinery | – | — | — | Industrials | 11.70 $ | +48.3 % | +56.9 % | +64.4 % | −0.6 % | +73.1 % | 78 | 97 | 9.6 % | 6.9 % | 1.47 | — | 8.6 | 0.3 | 1.4 | — | 0.73 | 2.0 | — | 1.0 % | -5.5 % | -17.8 % | -3.2 % | 1.66 | — | -20.8 % | 5 | 2.5 % | 7.9 % | 4.6 | 100.8 % | 10.5 % | 4.5 (2) |
| TBI TrueBlue Inc | 08/03 | -21 % | 69 % | Stage 2 | D 35 | 3 of 9 | 0.3 $ | Staffing & Employment Services | – | — | — | Industrials | 9.80 $ | +41.5 % | +50.6 % | +95.6 % | −16.1 % | +0.5 % | 78 | 11 | 5.5 % | 6.1 % | 1.73 | — | 10.6 | 0.2 | 1.1 | — | 0.76 | 85.2 | — | 21.5 % | -3.4 % | -19.1 % | -2.7 % | 0.51 | — | +3.1 % | 2 | 0.0 % | 0.0 % | 6.6 | 92.5 % | 2.6 % | 4.0 (2) |
| LASE Laser Photonics Corporation | 08/21 | -32 % | ⚠ Wildest 10% 168 % | Stage 3 | E 23 | 2 of 9 | 0.0 $ | Specialty Industrial Machinery | Sells AI | — | Industrials | 0.6821 $ | — | — | -80.9 % | −71.3 % | — | 77 | 3 | 16.3 % | 17.9 % | 2.58 | — | 0.0 | 5.9 | 3.4 | — | — | 28.8 | -303.2 % | -16.8 % | 0.0 % | -727.4 % | -57.7 % | — | -53.3 % | +132.0 % | 4 | 0.0 % | 0.0 % | -4.9 | 12.0 % | 11.1 % | 5.0 (1) | |
| RYZ Ryerson Holding Corporation | 08/04 | -7 % | 50 % | Stage 2 | B 59 | 5 of 9 | 1.6 $ | Metal Fabrication | – | — | — | Industrials | 31.20 $ | +11.0 % | -2.0 % | +43.4 % | −10.0 % | -7.1 % | 73 | 50 | 4.6 % | 4.2 % | 1.61 | — | 3.5 | 0.2 | 1.1 | — | — | 16.4 | 2.2 % | 17.3 % | 0.2 % | -4.3 % | 1.0 % | 1.01 | 34.4 % | -0.6 % | 2 | 2.4 % | 1.8 % | 6.4 | 96.0 % | 3.2 % | 3.0 (2) |
| CABA Cabaletta Bio Inc | 08/06 | -25 % | ⚠ Wildest 10% 90 % | Stage 2 | D 37 | 2 of 9 | 0.2 $ | Biotechnology | – | — | — | Healthcare | 1.50 $ | +37.9 % | +42.0 % | -36.6 % | −31.0 % | +846.4 % | 73 | 42 | 7.4 % | 7.4 % | 3.48 | — | 0.0 | — | — | — | — | -3.4 | — | — | 0.0 % | -156.0 % | -48.2 % | — | — | -100.0 % | 2 | 0.0 % | 0.0 % | -10.9 | 63.6 % | 25.1 % | 4.5 (10) |
| TKNO Alpha Teknova Inc | 08/06 | +21 % | 80 % | Stage 3 | B 55 | 5 of 9 | 0.4 $ | Drug Manufacturers - Specialty & Generic | – | — | — | Healthcare | 7.40 $ | +28.7 % | +38.0 % | +50.4 % | −18.3 % | +46.5 % | 71 | 42 | 9.2 % | 9.9 % | 0.86 | — | 0.0 | 9.0 | 7.2 | — | — | -6.2 | — | 34.6 % | -38.4 % | -23.9 % | -9.3 % | 0.23 | — | +7.4 % | 2 | 0.0 % | 0.0 % | 1.2 | 84.7 % | 14.9 % | 4.8 (8) |
| EYPT Eyepoint Pharmaceuticals Inc | 08/05 | -8 % | ⚠ Wildest 10% 234 % | Stage 1 | D 34 | 1 of 9 | 0.0 $ | Biotechnology | – | — | — | Healthcare | 0.3484 $ | -21.3 % | -22.7 % | -96.8 % | −28.3 % | +2,135.7 % | 59 | 42 | 6.7 % | 6.3 % | 1.68 | — | 6.2 | 10.7 | 0.1 | — | — | 11.6 | — | -9,235.0 % | 0.0 % | -102.7 % | -74.9 % | 0.09 | — | -27.5 % | 5 | 0.0 % | 0.0 % | -7.3 | 111.8 % | 26.0 % | 3.4 (13) |
| SMHI SEACOR Marine Holdings Inc | 07/29 | -10 % | 54 % | Stage 2 | D 42 | 3 of 9 | 0.3 $ | Marine Shipping | – | — | — | Industrials | 9.90 $ | +30.6 % | +26.7 % | +62.2 % | −7.6 % | +25.0 % | 59 | 42 | 8.4 % | 6.2 % | 1.16 | — | 0.0 | 1.3 | 1.1 | — | — | 7.0 | — | 16.5 % | -8.6 % | -10.6 % | -5.2 % | 1.33 | — | -16.0 % | 4 | 0.0 % | 0.0 % | 4.4 | 46.6 % | 3.9 % | 5.0 (1) |
| VUZI Vuzix Corp Cmn Stk | 08/13 | -13 % | ⚠ Wildest 10% 89 % | Stage 2 | D 31 | 4 of 9 | 0.2 $ | Consumer Electronics | – | — | — | Technology | 2.10 $ | -18.5 % | -14.4 % | -36.8 % | −51.1 % | +172.7 % | 57 | 42 | 8.6 % | 11.9 % | 1.75 | — | 0.0 | 30.8 | — | — | — | -1.1 | — | -9.6 % | 0.0 % | -91.9 % | -53.3 % | — | — | +9.1 % | 3 | 0.0 % | 0.0 % | -25.0 | 37.0 % | 21.8 % | 5.0 (1) |
| EFC Ellington Financial Inc. | 08/06 | +16 % | 18 % | Stage 2 | B 65 | 7 of 9 | 1.4 $ | REIT - Mortgage | Uses AI | — | — | Real Estate | 11.40 $ | +4.5 % | +4.8 % | +0.1 % | −3.3 % | +25.2 % | 56 | 87 | 1.7 % | 1.5 % | 0.97 | — | 9.1 | — | — | — | 0.86 | 0.0 | 59.4 % | 100.0 % | 51.5 % | 12.2 % | 1.2 % | — | 9.5 % | +139.0 % | 4 | 13.3 % | 21.9 % | 1.9 | 53.3 % | 10.7 % | 4.0 (8) |
| FF FutureFuel Corp | 08/10 | -7 % | 53 % | Stage 2 | C 50 | 5 of 9 | 0.3 $ | Specialty Chemicals | Threatened | — | Basic Materials | 5.70 $ | +29.7 % | +45.7 % | +50.1 % | −19.7 % | +141.4 % | 56 | 4 | 4.4 % | 4.2 % | 0.95 | — | 16.3 | 1.7 | 1.8 | — | — | 2.7 | — | -8.3 % | -17.2 % | -31.4 % | -8.0 % | — | — | -60.7 % | 4 | 0.7 % | 68.6 % | 6.6 | 36.0 % | 5.0 % | — | |
| KULR KULR Technology Group Inc | 08/13 | -9 % | ⚠ Wildest 10% 97 % | Stage 2 | D 40 | 4 of 9 | 0.1 $ | Electronic Components | – | — | — | Technology | 1.60 $ | +30.4 % | +11.8 % | -56.2 % | −52.9 % | +311.8 % | 56 | 42 | 9.7 % | 11.7 % | 2.33 | — | 128.2 | 4.4 | — | — | — | -6.4 | — | -14.9 % | 0.0 % | -77.3 % | -22.8 % | — | — | +50.6 % | 5 | 0.0 % | 0.0 % | 2.9 | 22.6 % | 14.5 % | 5.0 (2) |
| MWYN Marwynn Holdings, Inc. | — | — | ⚠ Wildest 10% 126 % | Stage 3 | D 36 | 4 of 9 | 0.0 $ | Furnishings, Fixtures & Appliances | – | — | — | Consumer Cyclical | 1.90 $ | +31.1 % | +18.9 % | +83.3 % | −53.3 % | — | 56 | 3 | 9.3 % | 9.9 % | — | — | 0.0 | 7.4 | 19.3 | — | — | 14.8 | — | 16.0 % | -24.7 % | -306.2 % | -6.2 % | 0.01 | — | -6.8 % | 4 | 0.0 % | 0.0 % | -14.6 | 0.6 % | 0.6 % | — |
| CHRS Coherus BioSciences Inc | 08/06 | -21 % | ⚠ Wildest 10% 84 % | Stage 4 | C 49 | 5 of 9 | 0.1 $ | Biotechnology | – | — | — | Healthcare | 0.8301 $ | +2.8 % | +8.2 % | -48.1 % | −43.4 % | +604.5 % | 55 | 7 | 6.0 % | 5.9 % | 0.99 | — | 41.2 | 2.6 | 1.6 | — | — | 3.5 | — | 69.0 % | -259.4 % | 33.1 % | -30.5 % | 0.69 | — | -84.2 % | 5 | 0.0 % | 0.0 % | -16.1 | 38.6 % | 15.6 % | 4.5 (6) |
| SMCI Super Micro Computer Inc | 08/04 | +18 % | ⚠ Wildest 10% 96 % | Stage 3 | B 71 | 4 of 9 | 22.7 $ | Computer Hardware | – | — | — | Technology | 33.00 $ | +13.8 % | -7.9 % | -34.6 % | −49.2 % | +23.3 % | 54 | 93 | 8.8 % | 9.6 % | 2.01 | 14.9 | 8.1 | 0.6 | 2.4 | — | 0.91 | 8.8 | 6.1 % | 10.8 % | 5.7 % | 17.9 % | 7.9 % | 0.89 | 32.3 % | +47.0 % | 6 | 0.0 % | 0.0 % | 8.6 | 62.5 % | 14.8 % | 3.1 (18) |
| PDSB PDS Biotechnology Corp | 08/12 | -28 % | ⚠ Wildest 10% 181 % | Stage 2 | D 39 | 1 of 9 | 0.1 $ | Biotechnology | – | — | — | Healthcare | 1.40 $ | +18.5 % | +0.6 % | +53.5 % | −44.8 % | +284.6 % | 53 | 42 | 9.6 % | 11.2 % | 1.17 | — | 0.0 | — | 16.2 | — | — | -2.6 | — | — | 0.0 % | -254.1 % | -70.6 % | 4.08 | — | — | 2 | 0.0 % | 0.0 % | -28.7 | 9.2 % | 3.9 % | 5.0 (2) |
| LZM Lifezone Metals Limited | 07/29 | -20 % | 80 % | Stage 4 | B 55 | 5 of 9 | 0.4 $ | Other Industrial Metals & Mining | – | — | — | Basic Materials | 3.80 $ | -0.5 % | -13.9 % | -27.3 % | −36.7 % | +177.6 % | 50 | 42 | 8.6 % | 8.6 % | 1.35 | — | 0.0 | 295.0 | — | — | — | -1.1 | — | 36.4 % | 0.0 % | -16.4 % | -7.0 % | — | — | +652.2 % | 3 | 0.0 % | 0.0 % | -9.1 | 25.8 % | 20.3 % | 5.0 (1) |
| RARE Ultragenyx | 08/04 | -14 % | ⚠ Wildest 10% 97 % | Stage 3 | C 47 | 0 of 9 | 1.6 $ | Biotechnology | – | — | — | Healthcare | 16.10 $ | +25.0 % | -11.3 % | -51.5 % | −31.0 % | +52.6 % | 48 | 42 | 5.5 % | 5.2 % | 0.35 | — | 0.0 | 2.2 | — | — | — | -6.5 | -102.2 % | -20.8 % | -81.7 % | -608.5 % | -24.2 % | — | -18.2 % | +20.1 % | 3 | 0.0 % | 0.0 % | -9.9 | 104.2 % | 21.4 % | 3.9 (21) |
| RGNX Regenxbio Inc | 08/06 | -16 % | ⚠ Wildest 10% 97 % | Stage 4 | D 39 | 1 of 9 | 0.4 $ | Biotechnology | – | — | — | Healthcare | 7.20 $ | -30.9 % | -18.2 % | -42.3 % | −36.8 % | +257.3 % | 46 | 42 | 13.1 % | 9.4 % | 1.13 | — | 0.0 | 2.1 | — | — | 0.26 | -3.4 | — | -45.0 % | -112.6 % | -196.4 % | -21.2 % | — | — | +104.5 % | 4 | 0.0 % | 0.0 % | -10.9 | 84.7 % | 15.4 % | 4.4 (12) |
| MATW Matthews International Corporation | 08/04 | -9 % | 34 % | Stage 1 | D 39 | 3 of 9 | 0.6 $ | Conglomerates | – | — | — | Industrials | 19.30 $ | +1.0 % | +1.8 % | -13.1 % | −14.8 % | +64.9 % | 45 | 96 | 3.5 % | 3.4 % | 1.05 | — | 11.1 | 0.5 | — | — | 1.86 | 10.9 | — | 37.9 % | -2.7 % | 2.1 % | -0.3 % | — | — | -16.6 % | 3 | 5.4 % | 137.8 % | 6.4 | 96.3 % | 21.3 % | 4.0 (3) |
| OSTX OS Therapies Incorporated | 08/17 | — | 74 % | Stage 3 | D 30 | 2 of 9 | 0.1 $ | Biotechnology | – | — | — | Healthcare | 1.20 $ | +30.0 % | +47.4 % | -31.6 % | −30.0 % | +608.3 % | 45 | 42 | 8.5 % | 8.3 % | -0.64 | — | 1.7 | — | 9.1 | — | — | 0.0 | — | — | 0.0 % | -914.0 % | -232.6 % | -0.12 | — | — | — | 0.0 % | 0.0 % | -78.9 | 6.5 % | 6.0 % | 4.8 (4) |
| AIRT Air T Inc | — | -5 % | 60 % | Stage 3 | D 43 | 3 of 9 | 0.1 $ | Conglomerates | – | — | — | Industrials | 27.90 $ | +20.4 % | +28.7 % | +25.8 % | −17.2 % | — | 44 | 83 | 5.8 % | 4.5 % | 0.21 | — | 12.8 | 0.2 | 1,118.4 | — | — | 2.9 | — | 22.7 % | 17.2 % | -48.3 % | -5.5 % | -191.88 | — | +1.8 % | 4 | 0.0 % | 0.0 % | 3.3 | 24.3 % | 2.6 % | — |
| CNVS Cineverse Corp. | 08/13 | +12 % | 58 % | Stage 3 | D 38 | 1 of 9 | 0.0 $ | Entertainment | – | — | — | Communication Services | 1.50 $ | +35.1 % | +34.0 % | -51.2 % | −63.7 % | +721.4 % | 43 | 42 | 10.7 % | 7.1 % | 1.71 | — | 38.8 | 0.4 | — | — | 0.46 | 6.3 | — | 46.3 % | -12.9 % | -24.5 % | -9.1 % | — | — | +59.1 % | 2 | 0.0 % | 0.0 % | -20.6 | 16.5 % | 1.9 % | 5.0 (2) |
| GUTS Fractyl Health, Inc. | 08/11 | — | ⚠ Wildest 10% 178 % | Stage 4 | D 43 | 5 of 9 | 0.2 $ | Biotechnology | Uses AI | — | Healthcare | 0.9765 $ | -62.4 % | -64.6 % | -93.4 % | −67.3 % | +4,081.8 % | 42 | 42 | 8.5 % | 9.6 % | 2.42 | — | 0.0 | — | 7.8 | — | — | 0.0 | — | 100.0 % | 0.0 % | -778.3 % | -74.6 % | 2.85 | — | -100.0 % | 3 | 0.0 % | 0.0 % | -18.4 | 52.5 % | 1.4 % | 4.7 (7) | |
| SANA Sana Biotechnology Inc | 08/10 | -26 % | 75 % | Stage 4 | D 38 | 2 of 9 | 0.7 $ | Biotechnology | – | — | — | Healthcare | 2.60 $ | -17.7 % | -23.8 % | -49.4 % | −50.2 % | +224.2 % | 41 | 50 | 7.7 % | 7.0 % | 2.19 | — | 0.0 | — | 6.2 | — | — | -1.1 | — | — | 0.0 % | -147.4 % | -29.2 % | 0.63 | — | — | — | 0.0 % | 0.0 % | -15.9 | 82.8 % | 23.0 % | 4.6 (9) |
| AOMR Angel Oak Mortgage Inc | 08/04 | +21 % | 24 % | Stage 3 | D 37 | 2 of 9 | 0.2 $ | REIT - Mortgage | – | — | — | Real Estate | 7.00 $ | +7.6 % | +11.2 % | -6.5 % | −13.9 % | +39.9 % | 41 | 10 | 3.2 % | 2.6 % | 1.21 | — | 5.5 | — | — | — | — | 0.0 | — | 69.9 % | 51.4 % | 6.3 % | 0.7 % | — | — | +158.1 % | 4 | 17.3 % | 1.6 % | 2.8 | 63.9 % | 5.8 % | 4.3 (6) |
| ELUT Elutia Inc. | 08/13 | -20 % | 75 % | Stage 2 | D 39 | 3 of 9 | 0.0 $ | Medical Devices | – | — | — | Healthcare | 0.8371 $ | +48.7 % | +71.0 % | -9.9 % | −64.1 % | +521.3 % | 41 | 42 | 7.1 % | 8.1 % | 0.84 | — | 0.0 | 4.0 | 1.8 | — | — | -3.3 | — | 57.8 % | 426.9 % | 0.0 % | -34.7 % | 0.52 | — | -49.6 % | 3 | 0.0 % | 0.0 % | -7.2 | 45.7 % | 0.0 % | 5.0 (1) |
| MXCT MaxCyte Inc | 08/05 | -25 % | 70 % | Stage 3 | C 47 | 3 of 9 | 0.2 $ | Medical Devices | – | — | — | Healthcare | 1.60 $ | -24.2 % | -22.5 % | +14.6 % | −46.4 % | +173.8 % | 40 | 42 | 6.6 % | 7.0 % | 1.49 | — | 0.0 | 5.7 | — | — | — | -11.1 | — | 79.2 % | -114.8 % | -21.3 % | -10.6 % | — | — | -14.5 % | 4 | 0.0 % | 0.0 % | 7.9 | 68.0 % | 1.1 % | 4.7 (6) |
| JFB JFB Construction Holdings | 08/13 | — | ⚠ Wildest 10% 141 % | Stage 4 | D 42 | 4 of 9 | 0.1 $ | Real Estate - Development | – | — | — | Real Estate | 4.90 $ | -33.0 % | -33.5 % | +72.4 % | −86.2 % | +83.7 % | 40 | 7 | 8.8 % | 8.9 % | — | — | 0.0 | 1.9 | 1.4 | — | — | 204.3 | — | 9.5 % | -23.9 % | -29.9 % | -20.1 % | 0.04 | — | +6.7 % | 4 | 0.0 % | 0.0 % | 9.3 | 4.7 % | 23.8 % | — |
| RCKT Rocket Pharmaceuticals Inc | 08/06 | -28 % | 69 % | Stage 4 | C 45 | 1 of 9 | 0.3 $ | Biotechnology | – | — | — | Healthcare | 2.40 $ | -1.1 % | -4.0 % | -32.8 % | −40.6 % | +273.0 % | 37 | 42 | 7.3 % | 6.4 % | 0.50 | — | 0.0 | — | — | — | — | 4.7 | — | — | 0.0 % | -64.4 % | -28.4 % | — | — | — | — | 0.0 % | 0.0 % | -10.4 | 89.9 % | 16.8 % | 3.9 (14) |
| PCT Purecycle Technologies Holdings Co | 08/06 | -4 % | ⚠ Wildest 10% 83 % | Stage 4 | C 46 | 2 of 9 | 0.7 $ | Pollution & Treatment Controls | – | — | — | Industrials | 3.40 $ | -3.5 % | -17.9 % | -72.6 % | −54.5 % | +231.2 % | 34 | 42 | 7.1 % | 8.1 % | 2.63 | — | 142.9 | 50.3 | 96.5 | — | — | -11.0 | — | -782.8 % | 0.0 % | -80.9 % | -10.2 % | 99.53 | — | — | 3 | 0.0 % | 0.0 % | -0.6 | 69.1 % | 44.7 % | 3.8 (5) |
| NXB NextBoat Inc. | 08/13 | — | – | Stage 1 | D 41 | 2 of 9 | 0.0 $ | Auto & Truck Dealerships | – | — | — | Consumer Cyclical | 1.50 $ | — | — | — | −28.6 % | +525.0 % | 34 | 42 | 13.0 % | 10.4 % | — | — | 0.0 | 0.3 | — | — | — | 146.8 | — | 11.4 % | -5.4 % | -101.0 % | -5.0 % | — | — | +21.1 % | 2 | 0.0 % | 0.0 % | 3.1 | 1.1 % | 0.6 % | — |
| PESI Perma-Fix Environmental Svcs Inc | 08/06 | 0 % | 64 % | Stage 4 | D 29 | 3 of 9 | 0.3 $ | Waste Management | Neutral | — | — | Industrials | 12.50 $ | -11.9 % | +3.6 % | -6.7 % | −25.8 % | +145.9 % | 34 | 15 | 7.2 % | 7.1 % | 0.56 | — | 99.0 | 4.6 | — | — | — | -31.4 | — | -2.8 % | -37.0 % | -28.5 % | -12.4 % | — | — | +4.3 % | 3 | 0.0 % | 0.0 % | -1.0 | 49.3 % | 16.1 % | 5.0 (1) |
| PRME Prime Medicine, Inc. | 08/06 | -26 % | ⚠ Wildest 10% 90 % | Stage 4 | D 43 | 1 of 9 | 0.9 $ | Biotechnology | Uses AI | — | Healthcare | 4.70 $ | -6.6 % | +4.2 % | +15.4 % | −54.2 % | +92.3 % | 32 | 42 | 10.1 % | 9.0 % | 2.38 | — | 0.0 | — | 12.3 | — | — | -3.1 | — | -3,489.5 % | 0.0 % | -216.1 % | -46.5 % | 1.49 | — | +55.3 % | 4 | 0.0 % | 0.0 % | -9.0 | 66.6 % | 22.6 % | 4.5 (14) | |
| ASLE AerSale Corp | 08/05 | -19 % | 37 % | Stage 4 | C 46 | 5 of 9 | 0.2 $ | Airports & Air Services | – | — | — | Industrials | 4.80 $ | -9.4 % | -11.8 % | -37.0 % | −29.3 % | +54.3 % | 31 | 88 | 4.3 % | 3.6 % | 0.38 | — | 20.2 | 0.7 | — | — | — | 16.6 | — | 28.9 % | -1.2 % | 2.5 % | 0.2 % | — | — | -2.8 % | 3 | 0.0 % | 0.0 % | 8.0 | 61.3 % | 8.1 % | 3.0 (2) |
| ELWT Elauwit Connection, Inc. | 08/13 | — | – | Stage 1 | D 29 | 3 of 9 | 0.0 $ | Telecom Services | – | — | — | Communication Services | 4.40 $ | +18.9 % | +30.7 % | — | −36.8 % | +85.2 % | 31 | 42 | 10.5 % | 10.2 % | — | — | 0.0 | 1.6 | 12.6 | — | — | 0.0 | — | 17.7 % | -45.3 % | 0.0 % | -47.8 % | 0.82 | — | +154.5 % | 5 | 0.0 % | 0.0 % | -4.6 | 8.6 % | 0.4 % | 5.0 (1) |
| REZI Resideo Technologies Inc | 08/04 | +26 % | 61 % | Stage 4 | C 50 | 5 of 9 | 2.8 $ | Industrial Distribution | – | — | — | Industrials | 18.70 $ | -13.0 % | -15.2 % | -38.1 % | −28.6 % | +63.0 % | 30 | 97 | 4.6 % | 4.7 % | 1.50 | — | 9.4 | 0.4 | 1.1 | — | — | 7.2 | 7.9 % | 29.2 % | 5.6 % | -15.8 % | 4.6 % | 1.20 | 35.6 % | +10.5 % | 3 | 0.0 % | 0.0 % | 5.1 | 99.1 % | 9.7 % | 4.3 (6) |
| CDZI Cadiz Inc | 08/12 | +1 % | 66 % | Stage 4 | D 36 | 3 of 9 | 0.4 $ | Utilities - Regulated Water | – | — | — | Utilities | 4.60 $ | -27.5 % | -32.0 % | -14.5 % | −47.6 % | +140.3 % | 29 | 42 | 6.6 % | 6.7 % | 1.73 | — | 61.7 | 32.5 | — | — | 1.51 | -25.1 | — | 27.1 % | 0.0 % | -111.3 % | -12.9 % | — | — | +69.8 % | 4 | 0.0 % | 0.0 % | -12.9 | 48.8 % | 18.7 % | 4.7 (3) |
| GANX Gain Therapeutics Inc | 08/11 | -20 % | ⚠ Wildest 10% 112 % | Stage 4 | D 40 | 5 of 9 | 0.0 $ | Biotechnology | – | — | — | Healthcare | 1.10 $ | -45.0 % | -38.5 % | -34.6 % | −60.4 % | +500.0 % | 29 | 42 | 6.7 % | 7.2 % | 0.19 | — | 0.0 | — | 3.2 | — | — | -1.5 | — | — | 0.0 % | -214.7 % | -95.5 % | 0.05 | — | -100.0 % | 2 | 0.0 % | 0.0 % | -14.5 | 19.2 % | 7.2 % | 4.8 (5) |
| RWT Redwood Trust Inc | 07/29 | +3 % | 43 % | Stage 1 | D 38 | 1 of 9 | 0.4 $ | REIT - Mortgage | – | — | — | Real Estate | 3.10 $ | -6.7 % | -5.9 % | -31.9 % | −32.1 % | +59.1 % | 28 | 14 | 3.2 % | 2.7 % | 1.51 | — | 6.2 | — | 0.4 | — | 1.47 | 0.0 | — | 80.9 % | 2.2 % | -8.6 % | 0.0 % | 26.42 | — | +356.5 % | 6 | 22.6 % | 78.3 % | 2.4 | 76.6 % | 23.5 % | 4.2 (9) |
| CMCO Columbus McKinnon Corporation | 07/29 | -21 % | 64 % | Stage 4 | D 44 | 3 of 9 | 0.4 $ | Farm & Heavy Construction Machinery | – | — | — | Industrials | 15.00 $ | -18.0 % | -18.3 % | +2.9 % | −39.4 % | +85.7 % | 27 | 78 | 6.5 % | 6.5 % | 1.43 | — | 10.9 | 0.3 | — | — | 0.46 | 9.8 | — | 35.1 % | -21.3 % | -19.7 % | 2.6 % | — | — | +23.9 % | 2 | 2.1 % | 13.4 % | 4.6 | 100.3 % | 32.6 % | 4.0 (4) |
| FBRX Forte Biosciences Inc | 08/13 | -23 % | ⚠ Wildest 10% 118 % | Stage 1 | D 25 | 3 of 9 | 0.4 $ | Biotechnology | – | — | — | Healthcare | 77.00 $ | -33.4 % | -22.3 % | +585.6 % | −47.7 % | -5.2 % | 26 | 42 | 7.7 % | 8.6 % | 2.65 | — | 0.0 | — | 10.3 | — | — | 1.9 | — | — | 0.0 % | -188.4 % | -37.8 % | — | — | -100.0 % | 2 | 0.0 % | 0.0 % | -10.3 | 74.8 % | 7.7 % | 5.0 (4) |
| MDAI Spectral AI Inc. | 08/11 | -28 % | 63 % | Stage 3 | D 27 | 1 of 9 | 0.0 $ | Medical Devices | – | — | — | Healthcare | 1.50 $ | +20.4 % | +17.4 % | -28.0 % | −48.0 % | +240.9 % | 26 | 42 | 4.9 % | 7.9 % | 1.21 | — | 52.4 | 2.9 | — | — | — | -3.4 | — | 42.9 % | -65.5 % | -2,308.3 % | -41.9 % | — | — | -33.6 % | 5 | 0.0 % | 0.0 % | -14.9 | 15.2 % | 8.2 % | 5.0 (1) |
| VANI Vivani Medical Inc. | 08/12 | -25 % | 63 % | Stage 4 | D 44 | 5 of 9 | 0.1 $ | Biotechnology | – | — | — | Healthcare | 1.10 $ | -3.3 % | -9.0 % | -35.6 % | −40.6 % | +248.5 % | 26 | 42 | 6.5 % | 5.4 % | 3.30 | — | 0.0 | — | — | — | — | -3.9 | — | — | 0.0 % | -176.4 % | -48.5 % | — | — | -100.0 % | 2 | 0.0 % | 0.0 % | -9.9 | 6.5 % | 1.1 % | 4.7 (3) |
| LMNR Limoneira Co | — | -4 % | 32 % | Stage 4 | D 34 | 2 of 9 | 0.2 $ | Farm Products | – | — | — | Consumer Defensive | 10.70 $ | +4.7 % | +2.1 % | -20.4 % | −23.6 % | +96.5 % | 25 | 85 | 3.4 % | 3.9 % | 0.33 | — | 13.6 | 1.5 | — | — | 5.92 | 31.3 | — | -8.1 % | -33.0 % | -23.3 % | -6.6 % | — | — | -16.6 % | 2 | 0.0 % | 73.2 % | 3.0 | 58.9 % | 7.2 % | 4.3 (3) |
| RCEL Avita Medical Ltd | 08/06 | -25 % | ⚠ Wildest 10% 85 % | Stage 1 | C 49 | 5 of 9 | 0.5 $ | Medical Devices | – | — | — | Healthcare | 15.70 $ | +13.6 % | +20.7 % | +352.9 % | −44.9 % | -10.6 % | 25 | 42 | 6.1 % | 7.4 % | 1.99 | — | 10.3 | 6.3 | — | — | — | -6.2 | — | 81.6 % | -57.0 % | -1,746.3 % | -41.6 % | — | — | +11.5 % | 3 | 0.0 % | 0.0 % | -33.3 | 17.2 % | 9.4 % | 5.0 (3) |
| GALT Galectin Therapeutics Inc | 08/13 | +39 % | ⚠ Wildest 10% 92 % | Stage 4 | D 33 | 5 of 9 | 0.2 $ | Biotechnology | – | — | — | Healthcare | 3.30 $ | -25.0 % | +23.3 % | -31.1 % | −40.7 % | +223.5 % | 25 | 42 | 14.5 % | 10.6 % | 0.38 | — | 4.5 | — | 162.0 | — | — | -4.0 | — | — | 0.0 % | -3,728.0 % | -64.2 % | -1.04 | — | — | 3 | 0.0 % | 0.0 % | -90.0 | 21.2 % | 12.0 % | 5.0 (1) |
| LE Lands’ End Inc | — | +11 % | 64 % | Stage 4 | B 61 | 5 of 9 | 0.3 $ | Apparel Retail | – | — | — | Consumer Cyclical | 9.50 $ | -21.6 % | -19.4 % | -38.9 % | −41.5 % | +100.0 % | 25 | 19 | 5.7 % | 6.1 % | 2.26 | — | 17.0 | 0.2 | — | — | 0.68 | 0.8 | — | 48.7 % | 26.6 % | 94.2 % | 3.3 % | — | — | -2.0 % | 6 | 0.0 % | 0.0 % | 9.8 | 39.4 % | 15.7 % | 5.0 (2) |
| SAFX XCF Global, Inc. | — | -33 % | ⚠ Wildest 10% 207 % | Stage 3 | D 41 | 5 of 9 | 0.0 $ | Utilities - Renewable | – | — | — | Utilities | 0.1225 $ | +67.3 % | -49.1 % | -85.3 % | −85.4 % | +605.2 % | 25 | 42 | 16.7 % | 14.6 % | -0.29 | 0.7 | 3.5 | 2.9 | 2.1 | — | — | 2.0 | — | -16.8 % | 0.0 % | 187.2 % | -5.8 % | 4.79 | — | — | 4 | 0.0 % | 0.0 % | -1.0 | 4.0 % | 2.9 % | 5.0 (1) |
| CV CapsoVision, Inc. | 08/13 | — | ⚠ Wildest 10% 96 % | Stage 1 | D 34 | 5 of 9 | 0.3 $ | Medical Devices | – | — | — | Healthcare | 6.80 $ | -39.2 % | -45.7 % | +48.5 % | −54.5 % | +39.7 % | 24 | 42 | 7.0 % | 7.4 % | — | — | 0.0 | 25.2 | 15.7 | — | — | 0.0 | — | 50.9 % | -214.7 % | -185.1 % | -132.5 % | 0.04 | — | +15.3 % | 4 | 0.0 % | 0.0 % | -15.7 | 8.1 % | 5.2 % | 5.0 (2) |
| PMT PennyMac Mortgage Investment Trust | 07/28 | +4 % | 29 % | Stage 4 | B 56 | 4 of 9 | 0.7 $ | REIT - Mortgage | Uses AI | — | — | Real Estate | 7.50 $ | -17.2 % | -10.3 % | -30.0 % | −23.9 % | +45.3 % | 23 | 63 | 3.0 % | 2.6 % | 1.17 | — | 8.4 | — | — | — | 0.76 | 5.7 | — | 82.9 % | 24.3 % | 7.6 % | 0.8 % | — | — | +245.8 % | 4 | 22.0 % | 112.7 % | 1.4 | 79.7 % | 15.8 % | 3.3 (9) |
| LXEO Lexeo Therapeutics, Inc. | 08/13 | — | 72 % | Stage 4 | C 45 | 3 of 9 | 0.2 $ | Biotechnology | – | — | — | Healthcare | 3.10 $ | -50.5 % | -54.5 % | -69.1 % | −57.2 % | +651.9 % | 23 | 50 | 7.5 % | 7.5 % | 1.64 | — | 7.5 | — | 1.1 | — | — | -6.0 | — | — | 0.0 % | -54.8 % | -27.6 % | 0.03 | — | -100.0 % | 2 | 0.0 % | 0.0 % | 13.5 | 115.5 % | 27.4 % | 4.8 (10) |
| ESLA Estrella Immunopharma Inc. | — | -32 % | ⚠ Wildest 10% 134 % | Stage 4 | D 43 | 3 of 9 | 0.0 $ | Biotechnology | – | — | — | Healthcare | 0.6393 $ | -35.9 % | -35.2 % | -70.4 % | −69.8 % | +1,187.1 % | 23 | 42 | 8.2 % | 8.7 % | 0.93 | — | 0.0 | — | 2.0 | — | — | -3.1 | — | — | 0.0 % | -268.5 % | -251.9 % | — | — | — | — | 0.0 % | 0.0 % | -54.7 | 12.2 % | 1.2 % | 5.0 (1) |
| FTCI FTC Solar Inc | 08/04 | -30 % | ⚠ Wildest 10% 112 % | Stage 4 | D 40 | 4 of 9 | 0.0 $ | Solar | – | — | — | Technology | 1.40 $ | -52.2 % | -58.7 % | -84.4 % | −64.2 % | +684.6 % | 22 | 42 | 9.6 % | 9.9 % | 1.77 | — | 18.8 | 0.2 | 3.6 | — | — | -0.7 | — | 3.0 % | -53.6 % | -955.8 % | -26.2 % | -3.81 | — | +110.5 % | 3 | 0.0 % | 0.0 % | -10.6 | 10.1 % | 11.8 % | 5.0 (3) |
| BMEA Biomea Fusion Inc | 08/04 | -32 % | ⚠ Wildest 10% 94 % | Stage 4 | C 46 | 5 of 9 | 0.0 $ | Biotechnology | – | — | — | Healthcare | 0.6395 $ | -0.8 % | +7.8 % | -54.5 % | −58.9 % | +859.9 % | 21 | 42 | 6.6 % | 7.7 % | -0.30 | — | 0.0 | — | — | — | — | -3.8 | — | — | 0.0 % | -189.4 % | -63.5 % | — | — | — | 2 | 0.0 % | 0.0 % | -30.1 | 38.9 % | 23.7 % | 4.3 (7) |
| BZAI Blaize Holdings, Inc. | 08/13 | -29 % | ⚠ Wildest 10% 142 % | Stage 4 | B 55 | 6 of 9 | 0.0 $ | Software - Application | – | — | — | Technology | 0.1956 $ | -24.1 % | -35.2 % | -95.0 % | −79.0 % | +802.5 % | 21 | 42 | 9.9 % | 10.8 % | 0.08 | — | 0.0 | 0.6 | 1.1 | — | — | 0.0 | — | 13.6 % | -160.9 % | -388.1 % | -91.8 % | 0.11 | — | +2,386.0 % | 6 | 0.0 % | 0.0 % | -19.8 | 34.7 % | 14.0 % | 4.3 (3) |
| BKKT Bakkt Holdings Inc | 08/10 | -30 % | ⚠ Wildest 10% 107 % | Stage 4 | E 24 | 3 of 9 | 0.2 $ | Software - Infrastructure | – | — | — | Technology | 4.60 $ | -11.7 % | -23.3 % | -80.5 % | −84.3 % | +150.0 % | 20 | 42 | 9.7 % | 10.7 % | 6.07 | — | 0.0 | — | 1.2 | — | — | 0.8 | — | -9.9 % | -2.8 % | -102.0 % | -25.0 % | 0.00 | — | -33.1 % | 4 | 0.0 % | 0.0 % | -7.7 | 21.4 % | 28.5 % | 5.0 (1) |
| BRID Bridgford Foods Corporation | — | -14 % | 38 % | Stage 4 | D 31 | 2 of 9 | 0.0 $ | Packaged Foods | – | — | — | Consumer Defensive | 5.40 $ | -13.8 % | -10.6 % | -34.4 % | −24.0 % | +44.2 % | 20 | 22 | 4.2 % | 3.9 % | -0.17 | — | 14.7 | 0.2 | — | — | 0.74 | 14.6 | — | 17.3 % | -6.4 % | -12.2 % | -8.6 % | — | — | +3.3 % | 3 | 0.0 % | 0.0 % | 9.7 | 5.5 % | 0.4 % | — |
| LUCD Lucid Diagnostics Inc | 08/12 | -8 % | 76 % | Stage 4 | C 47 | 7 of 9 | 0.1 $ | Medical Devices | – | — | — | Healthcare | 0.4048 $ | -5.5 % | -5.4 % | -65.4 % | −36.2 % | +813.0 % | 20 | 42 | 5.6 % | 6.1 % | 1.12 | — | 0.0 | 14.9 | — | — | — | -0.7 | — | -21.7 % | 0.0 % | -710.6 % | -81.6 % | — | — | +8.3 % | 5 | 0.0 % | 0.0 % | -33.6 | 19.4 % | 9.1 % | 4.6 (5) |
| TVGN Tevogen Bio Holdings Inc. | 08/18 | -33 % | ⚠ Wildest 10% 114 % | Stage 4 | D 25 | 4 of 9 | 0.0 $ | Biotechnology | – | — | — | Healthcare | 5.90 $ | -42.5 % | -68.2 % | -80.4 % | −20.7 % | -68.3 % | 20 | 42 | 12.9 % | 16.1 % | 0.20 | — | 0.0 | — | 0.0 | — | — | 18.3 | — | — | 0.0 % | 0.0 % | -297.4 % | -0.31 | — | — | — | 0.0 % | 0.0 % | -129.5 | 3.6 % | 0.5 % | 5.0 (1) |
| GNSS Genasys Inc | 08/13 | -13 % | 51 % | Stage 4 | B 62 | 6 of 9 | 0.1 $ | Scientific & Technical Instruments | – | — | — | Technology | 1.50 $ | -23.1 % | -20.3 % | -26.2 % | −39.3 % | +141.7 % | 18 | 3 | 5.6 % | 5.5 % | 0.73 | — | 12.3 | 1.1 | 21.7 | — | — | 128.6 | — | 49.3 % | -10.9 % | -144.2 % | -4.8 % | 5.74 | — | +69.8 % | 2 | 0.0 % | 0.0 % | -5.6 | 58.0 % | 2.0 % | 5.0 (3) |
| GPGI GPGI, Inc. | 08/06 | +54 % | 64 % | Stage 4 | D 44 | 2 of 9 | 3.2 $ | Metal Fabrication | – | — | — | Industrials | 11.20 $ | -24.8 % | -20.4 % | -41.4 % | −45.9 % | +33.9 % | 17 | 50 | 6.3 % | 5.7 % | 0.91 | — | 11.0 | — | — | — | — | 8.8 | -313,879.1 % | 195.8 % | 0.0 % | -25.9 % | -2.7 % | — | 91.3 % | -85.8 % | 4 | 0.1 % | 1.8 % | 13.4 | 88.6 % | 18.4 % | 3.0 (1) |
| BYSI BeyondSpring Inc | 08/12 | +11 % | ⚠ Wildest 10% 103 % | Stage 4 | D 30 | 2 of 9 | 0.0 $ | Biotechnology | – | — | — | Healthcare | 0.6438 $ | -1.2 % | -6.8 % | -71.8 % | −38.9 % | +170.5 % | 17 | 42 | 5.5 % | 8.6 % | -0.21 | — | 10.5 | — | 2.5 | — | — | 0.0 | — | 72.0 % | 0.0 % | -310.5 % | -22.9 % | -0.01 | — | -100.0 % | 4 | 0.0 % | 0.0 % | -72.8 | 14.6 % | 7.2 % | 5.0 (1) |
| STXS Stereotaxis Inc | 08/06 | +3 % | 52 % | Stage 4 | D 41 | 5 of 9 | 0.1 $ | Medical Instruments & Supplies | – | — | — | Healthcare | 0.8626 $ | -23.9 % | -28.8 % | -68.8 % | −54.9 % | +200.0 % | 17 | 42 | 6.2 % | 5.5 % | 1.37 | — | 19.6 | 2.8 | 6.1 | — | 1.31 | 151.4 | — | 55.6 % | -74.2 % | -156.1 % | -25.4 % | 0.27 | — | +20.3 % | 3 | 0.0 % | 0.0 % | -32.9 | 44.8 % | 6.7 % | 4.5 (4) |
| EXOZ eXoZymes, Inc. | 08/11 | — | 78 % | Stage 4 | E 21 | 2 of 9 | 0.0 $ | Biotechnology | – | — | — | Healthcare | 4.10 $ | -29.4 % | -32.5 % | -67.5 % | −59.8 % | — | 16 | 42 | 12.9 % | 9.0 % | — | — | 0.0 | — | 26.8 | — | — | 0.0 | — | — | 0.0 % | -185.8 % | -74.7 % | 0.76 | — | — | — | 0.0 % | 0.0 % | -31.3 | 0.7 % | 0.4 % | — |
| HDSN Hudson Technologies Inc | 07/29 | -13 % | 54 % | Stage 4 | D 42 | 4 of 9 | 0.2 $ | Specialty Chemicals | – | — | — | Basic Materials | 4.30 $ | -15.9 % | -21.3 % | -51.6 % | −47.1 % | +38.0 % | 15 | 5 | 3.9 % | 4.1 % | 0.83 | 12.7 | 14.1 | 0.7 | 0.7 | — | 0.29 | 11.4 | — | 23.3 % | 3.5 % | 5.9 % | 3.1 % | 0.02 | — | +4.0 % | 3 | 0.0 % | 0.0 % | 11.9 | 81.3 % | 6.5 % | 4.0 (4) |
| ATHR Aether Holdings, Inc. | — | — | ⚠ Wildest 10% 90 % | Stage 4 | D 34 | 4 of 9 | 0.0 $ | Software - Application | – | — | — | Technology | 2.70 $ | -48.4 % | -22.1 % | -54.3 % | −76.9 % | +260.0 % | 14 | 42 | 15.2 % | 10.7 % | — | — | 0.0 | 32.5 | — | — | — | 0.0 | — | 79.3 % | 0.0 % | -545.1 % | -57.8 % | — | — | -4.1 % | 5 | 0.0 % | 0.0 % | -10.9 | 1.0 % | 8.6 % | 5.0 (2) |
| AGEN Agenus Inc | 08/10 | -30 % | ⚠ Wildest 10% 107 % | Stage 4 | C 51 | 6 of 9 | 0.3 $ | Biotechnology | Neutral | — | Healthcare | 6.80 $ | -2.2 % | -6.0 % | +84.2 % | −60.8 % | +324.7 % | 13 | 42 | 7.3 % | 6.9 % | 1.32 | — | 3.7 | 2.2 | — | — | 1.44 | 2.2 | — | 113.6 % | 69.3 % | -1,278.8 % | 12.5 % | — | — | +10.4 % | 1 | 0.0 % | 0.0 % | -35.9 | 23.5 % | 15.3 % | 5.0 (3) |
Price Chart
Quarterly Figures
No quarterly data available.
Frequently Asked Questions
The mirror image of the Graham Net-Net shopping list: instead of companies with a bulging current-asset cushion, this scanner finds companies that are running out of cash. Criteria: the operating business is burning cash (operating cash flow over the trailing four quarters is negative in total), and cash plus short-term investments would last less than four quarters at the current burn rate.
All scanners are recalculated daily across the entire stock universe — most recently on November 2, 2026. The data basis is fundamental data and SEC filings (10-K annual reports and 10-Q quarterly reports).
Currently, 207 stocks pass this scanner's criteria (as of November 2, 2026). The 100 strongest hits are shown.
No global trading filters — this strategy checks the entire stock universe purely against its own criteria (mega caps over $50B included).
This scanner deliberately hunts for red flags — a hit is a finding, not a recommendation: like a smoke detector that beeps so you look in time. A hit is also not a bankruptcy verdict; most companies save themselves (say, through a capital raise, which dilutes existing shareholders). Portfolio owners use the list as an early-warning system, bargain hunters as an anti-shopping list, experienced traders as a watch list — it is never a buy or short recommendation.
Related scanners
- Altman Z: Distress Zone
- Bankruptcy Study: Stacked Warning Signals
- Below the 50- & 200-SMA
- Beneish M-Score
- Downward Momentum
- Going Concern (Distress Proxy)
- Kathy Donnelly: Liquid Movers Down
- Mike Webster: Overextended (Webby RSI)
- Near 52-Week Low
- Parabolic Death Cross
- Pradeep Bonde: $ Breakout Bearish
- Pradeep Bonde: 4% Breakout Bearish
- Qullamaggie: Parabolic (Short-Watch)
- RS Weakness (≤10)
- Stage 4 (Downtrend)
- Stan Weinstein: Stage 4
- Stan Weinstein: Stage 4B-
- Thomas Insolvency Candidate
- Weakness Cluster
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.